KMB - Kimberly-Clark Corporation

KMB

$96.81 0.35 (-0.36%) Last updated: Apr 16, 2026 00:33

52-Week Range

$96.81

$92.42 $96.81 $144.31

Fundamentals Overview

Kimberly-Clark Corporation is near the low of its 52-week range with moderate valuation, trading relatively flat today.

Valuation moderate

P/E 16 P/B 21.47 P/S 1.87

Intrinsic value (DCF)

+103.6% upside vs price

Profitability

Net margin 11.7%

Risk (Beta)

0.3 — lower vol

Earnings & growth

EPS $6.07 Rev -1.3% Profit +11.9% vs prior qtr

BullzEye Analysis

Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Buy — 72% confidence Risk: Lower Volatility — Beta 0.3. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +103.6% upside vs price · Analyst grade: B+ · Sentiment improving (2 upgrades)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$32.13B

P/E (TTM)

15.96

EPS (TTM)

$6.07

Dividend Yield

2.62%

52-Week Range

$92.42 - $144.31

Volume vs Avg

N/A

Beta

0.3

About

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus...

Sector: Consumer Defensive

Headquarters: US

Employees: 38,000

IPO Date: Mar 1980

Website: www.kimberly-clark.com

Beta: 0.3 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: B+. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 2, Equal Weight: 7, Hold: 4, In Line: 1, Neutral: 9, Outperform: 1, Overweight: 2, Sell: 3, Underweight: 1.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $197.07; current price is $96.81. That’s a +103.6% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric	Value
Valuation
P/E (TTM)	15.96
DCF value (model)	$197.07 (103.6% upside)
PEG (TTM)	N/A
P/B (TTM)	21.47
P/S (TTM)	1.87
P/FCF (TTM)	13.5
Liquidity & enterprise
Current Ratio (TTM)	0.75
Quick Ratio (TTM)	0.54
Cash Ratio (TTM)	0.1
Profitability
ROE (TTM)	N/A
ROA (TTM)	N/A
Revenue growth (YoY)	N/A
Net margin (TTM)	11.74%
Gross margin (TTM)	35.61%
Operating margin (TTM)	14.46%
Debt to equity (TTM)	N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for KMB.

Analyst Sentiment at a Glance

B+ Sentiment Improving

Buy 2Equal Weight 7Hold 4In Line 1Neutral 9Outperform 1Overweight 2Sell 3Underweight 1

2 upgrades, 1 downgrade

Price Target Consensus

Current $96.81

Median $110.00

Consensus $118.00

Low consensus $99.00

High consensus $162.00

Stock Grades (Institutions)

Institution	Action	Previous Grade	New Grade	Date
B of A Securities	maintain	Buy	Buy	2026-04-10
Wells Fargo	maintain	Equal Weight	Equal Weight	2026-04-08
UBS	maintain	Neutral	Neutral	2026-04-07
Deutsche Bank	maintain	Hold	Hold	2026-03-30
Piper Sandler	maintain	Overweight	Overweight	2026-03-13
UBS	maintain	Neutral	Neutral	2026-01-28
UBS	maintain	Neutral	Neutral	2026-01-14
Citigroup	maintain	Sell	Sell	2026-01-14
TD Cowen	maintain	Hold	Hold	2026-01-08
Wells Fargo	maintain	Equal Weight	Equal Weight	2026-01-05
Citigroup	maintain	Sell	Sell	2025-12-17
BNP Paribas Exane	maintain	Neutral	Neutral	2025-12-01
Argus Research	upgrade	Hold	Buy	2025-11-13
Morgan Stanley	maintain	Equal Weight	Equal Weight	2025-11-04
Wells Fargo	maintain	Equal Weight	Equal Weight	2025-11-04
TD Cowen	maintain	Hold	Hold	2025-11-04
Evercore ISI Group	downgrade	Outperform	In Line	2025-11-04
TD Cowen	maintain	Hold	Hold	2025-10-31
UBS	maintain	Neutral	Neutral	2025-10-31
JP Morgan	maintain	Neutral	Neutral	2025-10-31
JP Morgan	maintain	Neutral	Neutral	2025-10-10
Citigroup	maintain	Sell	Sell	2025-10-09
UBS	maintain	Neutral	Neutral	2025-10-08
Piper Sandler	maintain	Overweight	Overweight	2025-10-02
Barclays	maintain	Equal Weight	Equal Weight	2025-10-01
Wells Fargo	maintain	Equal Weight	Equal Weight	2025-09-25
Evercore ISI Group	maintain	Outperform	Outperform	2025-09-22
Barclays	maintain	Equal Weight	Equal Weight	2025-08-04
JP Morgan	upgrade	Underweight	Neutral	2025-08-04
JP Morgan	maintain	Underweight	Underweight	2025-07-25